Barclays Maintains Overweight on Omada Health, Lowers Price Target to $22
Benzinga Newsdesk 11 hours ago
Analyst RatingsNewsPrice Target
Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and lowers the price target from $24 to $22.
Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and lowers the price target from $24 to $22.